Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more
Star Combo Pharma Ltd (S66) - Total Liabilities
Latest total liabilities as of June 2025: AU$10.19 Million AUD
Based on the latest financial reports, Star Combo Pharma Ltd (S66) has total liabilities worth AU$10.19 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Star Combo Pharma Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how Star Combo Pharma Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Star Combo Pharma Ltd Competitors by Total Liabilities
The table below lists competitors of Star Combo Pharma Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yari Minerals Ltd
AU:YAR
|
Australia | AU$186.65K |
|
SWISS RE N (SR9.SG)
STU:SR9
|
Germany | €163.21 Billion |
|
CMX Gold & Silver Corp
PINK:CXXMF
|
USA | $863.73K |
|
good natured Products Inc
PINK:GDNPF
|
USA | $76.80 Million |
|
Hindprakash Industries Limited
NSE:HPIL
|
India | ₹548.02 Million |
|
Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret AS
IS:LINK
|
Turkey | TL497.79 Million |
|
SOPRA GROUP
BE:OR8
|
Germany | €4.18 Billion |
|
Energoaqua a.s.
PR:ENRGA
|
Czech Republic | Kč957.25 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Star Combo Pharma Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 3.09 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Star Combo Pharma Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Star Combo Pharma Ltd (2016–2025)
The table below shows the annual total liabilities of Star Combo Pharma Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$10.19 Million | +9.50% |
| 2024-06-30 | AU$9.30 Million | +3.76% |
| 2023-06-30 | AU$8.97 Million | +11.56% |
| 2022-06-30 | AU$8.04 Million | +12.75% |
| 2021-06-30 | AU$7.13 Million | -30.22% |
| 2020-06-30 | AU$10.22 Million | +36.12% |
| 2019-06-30 | AU$7.51 Million | +170.36% |
| 2018-06-30 | AU$2.78 Million | -23.62% |
| 2017-06-30 | AU$3.64 Million | +13.40% |
| 2016-06-30 | AU$3.21 Million | -- |